Literature DB >> 16508715

Pituitary function during severe and life-threatening illnesses.

C Gauna1, G H van den Berghe, A J van der Lely.   

Abstract

The catabolic state of prolonged critical illness is associated with a low activity of anterior pituitary functions. Before considering endocrine intervention in these conditions, a detailed understanding of the neuroendocrinology of the stress response is warranted. It is now clear that the acute phase and the later phase of critical illness behave differently from an endocrinological point of view. When the disease process becomes prolonged, there is a uniformly-reduced pulsatile secretion of anterior pituitary hormones with proportionally reduced concentrations of peripheral anabolic hormones. Apparently, there is a constant interaction between neuroendocrine and internal immunoregulatory mechanisms that assures the fine tuning of both the neuro-endocrine and the immune system, so that both are able to preserve homeostasis of patients during severe and life-threatening illnesses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16508715     DOI: 10.1007/s11102-006-6043-3

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  44 in total

1.  Complement C3a receptors in the pituitary gland: a novel pathway by which an innate immune molecule releases hormones involved in the control of inflammation.

Authors:  Karen Francis; B Mary Lewis; Hiroyasu Akatsu; Peter N Monk; Stuart A Cain; Maurice F Scanlon; B Paul Morgan; Jack Ham; Philippe Gasque
Journal:  FASEB J       Date:  2003-10-16       Impact factor: 5.191

Review 2.  Hormonal and metabolic strategies to attenuate catabolism in critically ill patients.

Authors:  Ilse Vanhorebeek; Greet Van den Berghe
Journal:  Curr Opin Pharmacol       Date:  2004-12       Impact factor: 5.547

3.  Anterior pituitary function in patients with newly diagnosed rheumatoid arthritis.

Authors:  E Templ; M Koeller; M Riedl; O Wagner; W Graninger; A Luger
Journal:  Br J Rheumatol       Date:  1996-04

Review 4.  Hypopituitarism after traumatic brain injury.

Authors:  Marta Bondanelli; Maria Rosaria Ambrosio; Maria Chiara Zatelli; Laura De Marinis; Ettore C degli Uberti
Journal:  Eur J Endocrinol       Date:  2005-05       Impact factor: 6.664

5.  Posterior pituitary dysfunction after traumatic brain injury.

Authors:  Amar Agha; Evan Thornton; Patrick O'Kelly; William Tormey; Jack Phillips; Christopher J Thompson
Journal:  J Clin Endocrinol Metab       Date:  2004-12       Impact factor: 5.958

6.  Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: screening study at 3 months after the brain injury.

Authors:  Gianluca Aimaretti; Maria Rosaria Ambrosio; Carolina Di Somma; Alessandra Fusco; Salvatore Cannavò; Maurizio Gasperi; Carla Scaroni; Laura De Marinis; Salvatore Benvenga; Ettore Carlo degli Uberti; Gaetano Lombardi; Franco Mantero; Enio Martino; Giulio Giordano; Ezio Ghigo
Journal:  Clin Endocrinol (Oxf)       Date:  2004-09       Impact factor: 3.478

7.  Growth hormone releasing hormone reverses endotoxin-induced localized inflammatory hyperalgesia without reducing the upregulated cytokines, nerve growth factor and gelatinase activity.

Authors:  Rabih S Talhouk; Nayef E Saadé; Ghassan Mouneimne; Cynthia A Masaad; Bared Safieh-Garabedian
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2004-07       Impact factor: 5.067

8.  Prolactin modulates survival and cellular immune functions in septic mice.

Authors:  Reiner Oberbeck; Daniel Schmitz; Klaus Wilsenack; Mark Schüler; Claudia Biskup; Manfred Schedlowski; Dieter Nast-Kolb; Michael S Exton
Journal:  J Surg Res       Date:  2003-08       Impact factor: 2.192

9.  Long-term anti-tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion.

Authors:  Rainer H Straub; Georg Pongratz; Jürgen Schölmerich; Frieder Kees; Thomas F Schaible; Christian Antoni; Joachim R Kalden; Hanns-Martin Lorenz
Journal:  Arthritis Rheum       Date:  2003-06

Review 10.  Insulin therapy for the critically ill patient.

Authors:  Greet Van den Berghe
Journal:  Clin Cornerstone       Date:  2003
View more
  5 in total

Review 1.  Hyperglycemia in aneurysmal subarachnoid hemorrhage: a potentially modifiable risk factor for poor outcome.

Authors:  Nyika D Kruyt; Geert Jan Biessels; J Hans DeVries; Merel J A Luitse; Marinus Vermeulen; Gabriel J E Rinkel; W Peter Vandertop; Yvo B Roos
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-14       Impact factor: 6.200

Review 2.  Care of the stroke patient: routine management to lifesaving treatment options.

Authors:  George A Lopez; Arash Afshinnik; Owen Samuels
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

3.  Relationship between gut and sepsis: Role of ghrelin.

Authors:  Undurti N Das
Journal:  World J Diabetes       Date:  2011-01-15

Review 4.  Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management.

Authors:  Nyika D Kruyt; Geert Jan Biessels; J Hans Devries; Yvo B Roos
Journal:  Nat Rev Neurol       Date:  2010-02-16       Impact factor: 42.937

Review 5.  Glycemic variability and acute ischemic stroke: the missing link?

Authors:  Emmanuel I González-Moreno; Carlos R Cámara-Lemarroy; José G González-González; Fernando Góngora-Rivera
Journal:  Transl Stroke Res       Date:  2014-08-03       Impact factor: 6.829

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.